Abram SV, Roach BJ, Fryer SL, Calhoun VD, et al. Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia. Mol Psychiatry 2022 Apr 14. pii: 10.1038/s41380-022-01502.
PMID: 35422467